Status:
RECRUITING
A Multi-omic Approach to the Identification of Novel Biomarkers in Early Charcot-Marie-Tooth 1A Disease (CMT1A)
Lead Sponsor:
University Medical Center Goettingen
Collaborating Sponsors:
Assistance Publique Hopitaux De Marseille
Conditions:
CMT
CMT (Charcot Marie Tooth Disease)
Eligibility:
All Genders
10-30 years
Brief Summary
The most common inherited neuropathy is Charcot-Marie-Tooth disease type 1A (CMT1A), caused by a duplication of the gene expressing PMP22. CMT1A patients develop symptoms in early childhood with varia...
Eligibility Criteria
Inclusion criteria:
- collaborative children, adolescents and young adults aged 10-30 years
- genetic diagnosis of CMT1A, or clinical diagnosis and genetic diagnosis in affected relatives
- able to walk with/ without support.
Exclusion Criteria:
- neuromuscular disorders other than CMT1A
- concomitant disease preventing correct patient evaluation and contraindication to qMRI
Key Trial Info
Start Date :
March 24 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 30 2026
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT07476365
Start Date
March 24 2025
End Date
September 30 2026
Last Update
April 13 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Medical Centre
Göttingen, Germany, 37075